Lista de obras -

A Decision-Making Algorithm for Initiation and Discontinuation of RRT in Severe AKI.

artículo científico publicado en 2017

AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19

artículo científico publicado en 2020

Accelerated Venovenous Hemofiltration as a Transitional Renal Replacement Therapy in the Intensive Care Unit

artículo científico publicado en 2020

Angiographic characteristics of coronary arterial segments progressing to myocardial infarction in patients with and without chronic kidney disease ⬇️

artículo científico publicado el 29 de agosto de 2012

Arrhythmia and Sudden Death in Hemodialysis Patients: Protocol and Baseline Characteristics of the Monitoring in Dialysis Study

artículo científico publicado en 2016

Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction

artículo científico publicado en 2014

Association of Changes in Creatinine and Potassium Levels After Initiation of Renin Angiotensin Aldosterone System Inhibitors With Emergency Department Visits, Hospitalizations, and Mortality in Individuals With Chronic Kidney Disease

scientific article published on 02 November 2018

Association of activated vitamin D use with myocardial fibrosis and capillary supply: results of an autopsy study

artículo científico publicado en 2015

Association of circulating angiogenesis inhibitors and asymmetric dimethyl arginine with coronary plaque burden

artículo científico publicado en 2015

CKD and Coronary Collateral Supply in Individuals Undergoing Coronary Angiography after Myocardial Infarction ⬇️

artículo científico publicado el 19 de abril de 2012

Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups

artículo científico publicado en 2019

Cardiovascular complications in chronic dialysis patients

artículo científico publicado en 2016

Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

artículo científico publicado en 2015

Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review

artículo científico publicado en 2019

Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

scientific article published on 01 October 2019

Comparative Effectiveness of Medical Therapy, Percutaneous Revascularization, and Surgical Coronary Revascularization in Cardiovascular Risk Subgroups of Patients With CKD: A Retrospective Cohort Study of Medicare Beneficiaries

artículo científico publicado en 2019

Comparative Utilization and Temporal Trends in Cardiac Stress Testing in U.S. Medicare Beneficiaries With and Without Chronic Kidney Disease

artículo científico publicado en 2018

Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment

scientific article published on 29 November 2019

Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage.

artículo científico publicado en 2017

Coronary vascular dysfunction and prognosis in patients with chronic kidney disease.

artículo científico publicado en 2012

Do implantable defibrillators help patients with CKD?

artículo científico publicado en 2014

Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug-Eluting Stents: A Meta-Analysis

scientific article published on 22 April 2019

ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD.

artículo científico publicado en 2017

Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial

artículo científico publicado en 2020

Early versus late initiation of renal replacement therapy in patients with acute kidney injury: a meta-analysis of randomised clinical trials

artículo científico publicado en 2017

Echocardiographic parameters and renal outcomes in patients with preserved renal function, and mild- moderate CKD.

artículo científico publicado en 2018

Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m2: Subgroup Analysis of the Randomized CREDENCE Trial

scientific article published on 19 November 2020

Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial

artículo científico publicado en 2019

End-Stage Renal Disease and Arrhythmic Death

artículo científico publicado en 2018

Epidemiology and Natural History of the Cardiorenal Syndromes in a Cohort with Echocardiography

artículo científico publicado en 2017

Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%: Results From the CREDENCE Trial

scientific article published on 11 November 2019

Extracorporeal Stromal Cell Therapy for Subjects With Dialysis-Dependent Acute Kidney Injury

scientific article published on 02 June 2018

How is the heart best protected in chronic dialysis patients?: Between Scylla and Charybdis: what is the appropriate role for percutaneous coronary revascularization and coronary artery bypass grafting in patients on dialysis?

artículo científico

Identification of ESRD in Cardiovascular Procedural Databases

scientific article published on 03 July 2019

Impending Shortages of Kidney Replacement Therapy for COVID-19 Patients

scientific article published on 28 April 2020

Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney disease.

artículo científico publicado en 2014

Indications for Hospitalization of Patients With Hyperkalemia

Introduction: Cardiovascular Disease in Chronic Kidney Disease

artículo científico publicado en 2018

Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease

artículo científico publicado en 2014

Long-term outcomes of patients with stable coronary disease and chronic kidney dysfunction: 10-year follow-up of the Medicine, Angioplasty, or Surgery Study II Trial

scientific article published on 24 December 2018

Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy ⬇️

artículo científico publicado el 23 de agosto de 2010

Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease

artículo científico publicado en 2019

Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Stable Angina in Advanced CKD: A Decision Analysis.

artículo científico publicado en 2016

Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease

artículo científico publicado en 2016

Relation of Serum and Urine Renal Biomarkers to Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndromes (From the EXAMINE Trial)

scientific article published on 06 November 2018

Risks of Death and End-Stage Renal Disease After Surgical Compared With Percutaneous Coronary Revascularization in Elderly Patients With Chronic Kidney Disease ⬇️

artículo científico publicado el 11 de septiembre de 2012

Risks of Death and Graft Failure After Surgical Versus Percutaneous Coronary Revascularization in Renal Transplant Patients ⬇️

artículo científico publicado el 12 de febrero de 2013

SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis

artículo científico publicado en 2019

Serum glucose and phosphorus concentrations during continuous renal replacement therapy using commercial replacement solutions with or without phosphorus

scientific article published on 29 April 2020

Shades of grey: the conundrum of implantable defibrillators in individuals with advanced CKD

artículo científico publicado en 2015

Spironolactone in Dialysis: What's Old Is New Again.

artículo científico publicado en 2016

Strategies for Postmarketing Surveillance of Drugs and Devices in Patients with ESRD Undergoing Dialysis ⬇️

artículo científico publicado el 22 de agosto de 2013

The Authors Reply

artículo científico publicado en 2018

The Use of a Multidimensional Measure of Dialysis Adequacy-Moving beyond Small Solute Kinetics

artículo científico publicado en 2017

The axis of local cardiac endogenous Klotho-TGF-β1-Wnt signaling mediates cardiac fibrosis in human

scientific article published on 11 September 2019

Trends in the Use and Outcomes of Implantable Cardioverter-Defibrillators in Patients Undergoing Dialysis in the United States ⬇️

artículo científico publicado el 12 de junio de 2011

Lista de obras de

A Decision-Making Algorithm for Initiation and Discontinuation of RRT in Severe AKI.

AKI Treated with Renal Replacement Therapy in Critically Ill Patients with COVID-19

Accelerated Venovenous Hemofiltration as a Transitional Renal Replacement Therapy in the Intensive Care Unit

Angiographic characteristics of coronary arterial segments progressing to myocardial infarction in patients with and without chronic kidney disease ⬇️

Arrhythmia and Sudden Death in Hemodialysis Patients: Protocol and Baseline Characteristics of the Monitoring in Dialysis Study

Association between renal function and cardiovascular structure and function in heart failure with preserved ejection fraction

Association of Changes in Creatinine and Potassium Levels After Initiation of Renin Angiotensin Aldosterone System Inhibitors With Emergency Department Visits, Hospitalizations, and Mortality in Individuals With Chronic Kidney Disease

Association of activated vitamin D use with myocardial fibrosis and capillary supply: results of an autopsy study

Association of circulating angiogenesis inhibitors and asymmetric dimethyl arginine with coronary plaque burden

CKD and Coronary Collateral Supply in Individuals Undergoing Coronary Angiography after Myocardial Infarction ⬇️

Canagliflozin and Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus and Chronic Kidney Disease in Primary and Secondary Cardiovascular Prevention Groups

Cardiovascular complications in chronic dialysis patients

Cause of Death in Patients With Diabetic CKD Enrolled in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

Chronic Kidney Disease and Coronary Artery Disease: JACC State-of-the-Art Review

Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Comparative Effectiveness of Medical Therapy, Percutaneous Revascularization, and Surgical Coronary Revascularization in Cardiovascular Risk Subgroups of Patients With CKD: A Retrospective Cohort Study of Medicare Beneficiaries

Comparative Utilization and Temporal Trends in Cardiac Stress Testing in U.S. Medicare Beneficiaries With and Without Chronic Kidney Disease

Coronary Microvascular Dysfunction, Left Ventricular Remodeling, and Clinical Outcomes in Patients With Chronic Kidney Impairment

Coronary flow reserve is predictive of the risk of cardiovascular death regardless of chronic kidney disease stage.

Coronary vascular dysfunction and prognosis in patients with chronic kidney disease.

Do implantable defibrillators help patients with CKD?

Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug-Eluting Stents: A Meta-Analysis

ESRD After Heart Failure, Myocardial Infarction, or Stroke in Type 2 Diabetic Patients With CKD.

Early Change in Albuminuria with Canagliflozin Predicts Kidney and Cardiovascular Outcomes: A Post Hoc Analysis from the CREDENCE Trial

Early versus late initiation of renal replacement therapy in patients with acute kidney injury: a meta-analysis of randomised clinical trials

Echocardiographic parameters and renal outcomes in patients with preserved renal function, and mild- moderate CKD.

Effects of Canagliflozin in Patients with Baseline eGFR <30 ml/min per 1.73 m2: Subgroup Analysis of the Randomized CREDENCE Trial

Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial

End-Stage Renal Disease and Arrhythmic Death

Epidemiology and Natural History of the Cardiorenal Syndromes in a Cohort with Echocardiography

Evaluating the Effects of Canagliflozin on Cardiovascular and Renal Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease According to Baseline HbA1c, Including Those With HbA1c <7%: Results From the CREDENCE Trial

Extracorporeal Stromal Cell Therapy for Subjects With Dialysis-Dependent Acute Kidney Injury

How is the heart best protected in chronic dialysis patients?: Between Scylla and Charybdis: what is the appropriate role for percutaneous coronary revascularization and coronary artery bypass grafting in patients on dialysis?

Identification of ESRD in Cardiovascular Procedural Databases

Impending Shortages of Kidney Replacement Therapy for COVID-19 Patients

Increased concentration of circulating angiogenesis and nitric oxide inhibitors induces endothelial to mesenchymal transition and myocardial fibrosis in patients with chronic kidney disease.

Indications for Hospitalization of Patients With Hyperkalemia

Introduction: Cardiovascular Disease in Chronic Kidney Disease

Is left ventricular hypertrophy a modifiable risk factor in end-stage renal disease

Long-term outcomes of patients with stable coronary disease and chronic kidney dysfunction: 10-year follow-up of the Medicine, Angioplasty, or Surgery Study II Trial

Loss of Hypoxia-Inducible Factor Prolyl Hydroxylase Activity in Cardiomyocytes Phenocopies Ischemic Cardiomyopathy ⬇️

Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease

Percutaneous Coronary Intervention Versus Optimal Medical Therapy for Stable Angina in Advanced CKD: A Decision Analysis.

Reduced risk of myocardial infarct and revascularization following coronary artery bypass grafting compared with percutaneous coronary intervention in patients with chronic kidney disease

Relation of Serum and Urine Renal Biomarkers to Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Recent Acute Coronary Syndromes (From the EXAMINE Trial)

Risks of Death and End-Stage Renal Disease After Surgical Compared With Percutaneous Coronary Revascularization in Elderly Patients With Chronic Kidney Disease ⬇️

Risks of Death and Graft Failure After Surgical Versus Percutaneous Coronary Revascularization in Renal Transplant Patients ⬇️

SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis

Serum glucose and phosphorus concentrations during continuous renal replacement therapy using commercial replacement solutions with or without phosphorus

Shades of grey: the conundrum of implantable defibrillators in individuals with advanced CKD

Spironolactone in Dialysis: What's Old Is New Again.

Strategies for Postmarketing Surveillance of Drugs and Devices in Patients with ESRD Undergoing Dialysis ⬇️

The Authors Reply

The Use of a Multidimensional Measure of Dialysis Adequacy-Moving beyond Small Solute Kinetics

The axis of local cardiac endogenous Klotho-TGF-β1-Wnt signaling mediates cardiac fibrosis in human

Trends in the Use and Outcomes of Implantable Cardioverter-Defibrillators in Patients Undergoing Dialysis in the United States ⬇️